General Publications October 2023

“Regulating Laboratory Developed Tests Back on FDA’s ‘Front Burner,’” Policy & Medicine Compliance Update, October 2023.

This article explores the history and implications of the FDA’s proposed rule classifying LTDs as devices under the Federal Food, Drug, and Cosmetic Act.
Meet the Author
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.